The second wave of COVID-19 had affected Armenia quite badly. After the pandemic, the country has been working towards promoting its pharmaceutical and healthcare industry with renewed vigor. The pharmaceutical and healthcare industry in Armenia has witnessed significant growth and development in recent years. The country has made substantial efforts to improve its healthcare system and attract investments in the pharmaceutical sector. Armenia has a well-established infrastructure for healthcare services, with a network of hospitals, clinics, and medical centers across the country.
In terms of pharmaceutical production, Armenia has been gradually expanding its capabilities. The country has several pharmaceutical manufacturing companies that produce a wide range of drugs, including generic and innovative medicines. These companies not only cater to the local market but also export their products to neighboring countries. Furthermore, Armenia has been actively collaborating with international pharmaceutical companies, leading to the establishment of joint ventures and technology transfers.
According to industry statistics, the pharmaceutical sector in Armenia has shown positive growth in recent years. In 2020, the total pharmaceutical market size in Armenia was estimated to be around $500 million. The sector has experienced an annual growth rate of approximately 10% over the past decade. The government has also implemented policies to promote the local production of pharmaceuticals and reduce dependency on imports. This has increased the number of registered pharmaceutical manufacturers in the country. Additionally, Armenia has been working on enhancing its regulatory framework to ensure the quality and safety of pharmaceutical products.
The pharmaceutical and healthcare industry in Armenia holds great potential for further development and is poised to contribute to the country's economic growth and the well-being of its population. Aruvian Research presents an in-depth analysis of the Pharmaceutical and Healthcare Industry of Armenia in its research report Pharmaceutical and Healthcare Industry in Armenia 2023. The report covers the following data:
• An in-depth coverage of the pharmaceutical and healthcare industry in Armenia by sectors along with an analysis of how the COVID-19 pandemic is effecting the industry.
• We analyze the segments of prescription drugs, generic drugs, OTC medicines, and also analyze the landscape for medical research and clinical trials in Armenia.
• A SWOT analysis of the Armenian pharmaceutical and healthcare industry.
• The report incorporates a thorough assessment of market competitiveness through a Porter's Five Forces Analysis, evaluating the bargaining power of buyers and suppliers, the threat of new entrants, the threat of substitutes, and the intensity of competitive rivalry.
• Additionally, the report includes a comprehensive PEST analysis, examining the political, economic, social, and technological factors that impact the industry's growth and development.
• We take an up-close view of the regulatory framework governing the Armenian pharmaceutical and healthcare industry, and the challenges being faced in terms of intellectual property rights.
• Competition in the industry, along with an analysis of the both the domestic and multinational players in the sector like Liqvor, Arpimed, PharmaTech, AstraZeneca, Johnson & Johnson, Novartis, Takeda and many others are included.
• An industry forecast up to 2030 provides insights into the growth potential of each segment, including pharmaceuticals, medical devices, hospitals, clinics, and other healthcare services.
Aruvian Research’s report on the Pharmaceutical and Healthcare Industry in Armenia 2023 offers a comprehensive and in-depth assessment of the industry's future prospects, encompassing a detailed examination of various segments. The report provides a thorough analysis of the industry's dynamics, including market trends, challenges, and opportunities.
The report utilizes a data-driven approach, incorporating historical data, market trends, and expert insights to provide accurate and reliable forecasts. It explores factors such as population demographics, disease prevalence, healthcare infrastructure, and regulatory environment to project the future market size, revenue, and growth rate for each segment.
By combining industry analysis, forecasting, and comprehensive insights, this research report equips stakeholders, investors, and industry players with the necessary information to make informed decisions and capitalize on opportunities within the Armenian Pharmaceutical and Healthcare Industry.
Pharmaceutical and Healthcare Industry in Armenia 2023
A. Executive Summary
B. Industry Definition
C. Brief View of the CEE Pharmaceutical & Healthcare Sector
D. Pharmaceutical & Healthcare Industry in Armenia
D.1 Impact of COVID-19 on the Industry
D.2 Pharmaceutical Sector Analysis
D.3 Healthcare Sector Analysis
D.4 Telemedicine in Armenia
D.5 Research & Development in the Industry
D.6 Clinical Trials in Armenia
E. Armenia Pharmaceutical & Healthcare Industry: SWOT Analysis
E.1 Strengths to Build Upon
E.2 Weaknesses to Overcome
E.3 Opportunities to Exploit
E.4 Threats to Overcome
F. Armenia Pharmaceutical & Healthcare Industry: Porter’s Five Forces Strategy Analysis
F.2 Bargaining Power of Buyers
F.3 Bargaining Power of Suppliers
F.4 Competitive Rivalry in the Industry
F.5 Threat of New Entrants
F.6 Threat of Substitutes
G. Armenia Pharmaceutical & Healthcare Industry: PEST Analysis
G.1 Political Factors
G.2 Economic Factors
G.3 Social Factors
G.4 Technological Factors
H. Chronic Medical Conditions in Armenia
H.3 Cardiovascular Disease
I. Regulatory Framework of the Industry
I.1 Regulatory Landscape
I.2 Regulations for Medicine Pricing
I.3 Regulations for Medicine Reimbursement
I.4 Challenges with Intellectual Property Rights
J. Import/Export of Pharmaceuticals in Armenia
K. Competition in the Industry
K.1 Competitive Landscape
K.2 Competition in Generic Drugs Sector
K.3 Competition in the Armenian Pharmacy Sector
L. Forecast: Pharmaceutical & Healthcare Industry in Armenia
L.1 Outlook of the Pharmaceutical Industry in Armenia
L.2 Outlook of the Healthcare Industry in Armenia
M. Major Domestic & Multinational Players
M.3.1 Corporate Analysis
M.3.2 Business Segment Analysis
M.3.3 SWOT Analysis
M.4.1 Corporate Analysis
M.4.2 Business Segment Analysis
M.4.3 Financial Analysis
M.4.4 SWOT Analysis
M.5.1 Corporate Analysis
M.5.2 Business Segment Analysis
M.5.3 Financial Analysis
M.5.4 SWOT Analysis
M.6.1 Corporate Analysis
M.6.2 Business Segment Analysis
M.6.3 Financial Analysis
M.6.4 SWOT Analysis
M.7 Johnson & Johnson
M.7.1 Corporate Analysis
M.7.2 Business Segment Analysis
M.7.3 Financial Analysis
M.7.4 SWOT Analysis
M.8 Merck & Co.
M.8.1 Corporate Analysis
M.8.2 Business Segment Analysis
M.8.3 Financial Analysis
M.8.4 SWOT Analysis
M.9.1 Corporate Analysis
M.9.2 Business Segment Analysis
M.9.3 Financial Analysis
M.9.4 SWOT Analysis
M.10.1 Corporate Analysis
M.10.2 Business Segment Analysis
M.10.3 Financial Analysis
M.10.4 SWOT Analysis
M.11 Sanofi SA
M.11.1 Corporate Analysis
M.11.2 Business Segment Analysis
M.11.3 Financial Analysis
M.11.4 SWOT Analysis
M.12 Takeda Pharmaceutical
M.12.1 Corporate Analysis
M.12.2 Business Segment Analysis
M.12.3 Financial Analysis
M.12.4 SWOT Analysis
N. Glossary of Terms
O. Research Methodology